Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction

被引:204
作者
Shaikh, RB
Santee, S
Granger, SW
Butrovich, K
Cheung, T
Kronenberg, M
Cheroutre, H
Ware, CF
机构
[1] La Jolla Inst Allergy & Immunol, Div Dev Immunol, San Diego, CA 92121 USA
[2] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA 92121 USA
[3] Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA
关键词
D O I
10.4049/jimmunol.167.11.6330
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
LIGHT, a member of the TNF family of cytokines (homologous to lymphotoxin, exhibits inducible expression and competes with HSV glycoprotein D for herpesvirus entry mediator, a receptor expressed on T cells), is induced on activated T cells and mediates costimulatory and antitumor activity in vitro. Relatively little information is available on the in vivo effects of LIGHT expression, particularly within the T cell compartment. In this work, we describe transgenic mice that express human LIGHT under the control of the CD2 promoter, resulting in constitutive transgene expression in cells of the T lymphocyte lineage. LIGHT-transgenic animals exhibit abnormalities in both lymphoid tissue architecture and the distribution of lymphocyte subsets. They also show signs of inflammation that are most severe in the intestine, along with tissue destruction of the reproductive organs. These LIGHT-mediated effects were recapitulated when immune-deficient mice were reconstituted with bone marrow from LIGHT-transgenic donor mice. T cells in the LIGHT-transgenic mice have an activated phenotype and mucosal T cells exhibit enhanced Th1 cytokine activity. The results indicate that LIGHT may function as an important regulator of T cell activation, and implicate LIGHT signaling pathways in inflammation focused on mucosal tissues.
引用
收藏
页码:6330 / 6337
页数:8
相关论文
共 30 条
[1]  
Aranda R, 1997, J IMMUNOL, V158, P3464
[2]   Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines [J].
Browning, JL ;
Miatkowski, K ;
Sizing, I ;
Griffiths, D ;
Zafari, M ;
Benjamin, CD ;
Meier, W ;
Mackay, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :867-878
[3]   Nonlymphocyte-derived tumor necrosis factor is required for induction of colitis in recombination activating gene (RAG)2-/- mice upon transfer of CD4+CD45RBhi T cells [J].
Corazza, N ;
Eichenberger, S ;
Eugster, HP ;
Mueller, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1479-1491
[4]   Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein [J].
Ettinger, R ;
Browning, JL ;
Michie, SA ;
vanEwijk, W ;
McDevitt, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13102-13107
[5]  
FORCE WR, 1995, J IMMUNOL, V155, P5280
[6]   Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth [J].
Harrop, JA ;
McDonnell, PC ;
Brigham-Burke, M ;
Lyn, SD ;
Minton, J ;
Tan, KB ;
Dede, K ;
Spampanato, J ;
Silverman, C ;
Hensley, P ;
DiPrinzio, R ;
Emery, JG ;
Deen, K ;
Eichman, C ;
Chabot-Fletcher, M ;
Truneh, A ;
Young, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (42) :27548-27556
[7]   Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: Implications for joint and gut-associated immunopathologies [J].
Kontoyiannis, D ;
Pasparakis, M ;
Pizarro, TT ;
Cominelli, F ;
Kollias, G .
IMMUNITY, 1999, 10 (03) :387-398
[8]   Do mucosal T cells prevent intestinal inflammation? [J].
Kronenberg, M ;
Cheroutre, H .
GASTROENTEROLOGY, 2000, 118 (05) :974-977
[9]   Human immunodeficiency virus type 1 Nef mediates sustained membrane expression of tumor necrosis factor and the related cytokine LIGHT on activated T cells [J].
Lama, J ;
Ware, CF .
JOURNAL OF VIROLOGY, 2000, 74 (20) :9396-9402
[10]   The TNF and TNF receptor superfamilies: Integrating mammalian biology [J].
Locksley, RM ;
Killeen, N ;
Lenardo, MJ .
CELL, 2001, 104 (04) :487-501